KneeAlign provides both tibial and femoral navigation in a palm-sized, single-use device and is compatible with all implant systems. KneeAlign has been used in more than 18,000 cases, worldwide.
“As we continue building on our international growth strategy, we believe the U.K. surgeon community is poised to embrace OrthAlign technology,” said James Young Kim, OrthAlign’s vice president of marketing. “More than 70,000 knee replacements are performed in England and Wales each year, and the number is growing at a rapid rate. Competition amongst implant companies proves to be increasingly fierce, but the U.K. orthopedic market confirms that the future for TKAs lies in technology that improves results, promotes consistency, reduces operating time, decreases patient hospital stays, and reduces patient pain. Ultimately, we hope that our technology helps raise the standard of care for TKAs in the UK.”
More articles on devices:
aap Implantate receives patent for LOQTEQ
NuVasive COO sells 2.5k shares in $87k transaction
$0.9B by 2019: 3D printing in medical applications market analysis
